Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvingtrans Regulatory News (AVG)

Share Price Information for Avingtrans (AVG)

Share Price is delayed by 15 minutes
Get Live Data
652.00    0.00 (0.00%)
Bid:
644.00
Ask:
660.00
Spread: 16.00 (2.484%)
Market Cap: £219.22m
AVG Live PriceLast checked at - London Stock Exchange

Intraday Avingtrans Share Chart

Holding(s) in Company

17 May 2007 16:58

Avingtrans PLC17 May 2007 TR-1(i): NOTIFICATION OF MAJOR INTERESTS IN SHARES 1. Identity of the issuer or the underlying issuer of existing shares to whichvoting rights are attached (ii): Avingtrans plc 2. Reason for the notification (please state Yes/No): ( ) An acquisition or disposal of voting rights: ( no ) An acquisition or disposal of financial instruments which may result in theacquisition of shares already issued to which voting rights are attached: ( no ) An event changing the breakdown of voting rights: ( no ) Other (please specify) : ( Yes - Change in issued share capital) 3. Full name of person(s) subject to the notification obligation (iii): Bluehone Investors LLP 4. Full name of shareholder(s) (if different from 3.) (iv): See box 9 below 5. Date of the transaction (and date on which the threshold is crossed orreached if different) (v): 15/05/07 6. Date on which issuer notified: 16/05/07 7. Threshold(s) that is/are crossed or reached: 12% 8. Notified details: N/A A: Voting rights attached to shares Class/type of shares if possible using Situation previous to the Triggeringthe ISIN CODE transaction (vi) Number of Number of voting Rights shares (viii) GB0009188797 2,101,000 2,101,000 Resulting situation after the triggering transaction (vii) Class/type of shares if Number of Number of voting % of voting rightspossible using the ISIN CODE shares rights (ix) Direct Direct Indirect Direct Indirect (x) (xi) 2,101,000 2,101,000 B: Financial Instruments Resulting situation after the triggering transaction (xii) Type of Expiration Exercise/ Number of voting rights that may % offinancial Date Conversion be acquired if the instrument is votinginstrument (xiii) Period/ Date exercised/ converted. rights (xiv) N/A Total (A+B)Number of voting rights % of voting rights 2,101,000 11.95% 9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable (xv): Client No of voting rights % of total voting right Registered nameAIM VCT2 plc 667,000 3.80 Chase Nominees LimitedActiveCapital 1,267,000 7.21 Chase Nominees Limitedtrust plc Proxy Voting: 10. Name of the proxy holder: Bluehone Investors LLP 11. Number of voting rights proxy holder will cease to hold: N/A 12. Date on which proxy holder will cease to hold voting rights: N/A 13. Additional information: N/A 14. Contact name: Mike Bassi, F & C Asset Management plc, Administrators to Bluehone Investors LLP 15. Contact telephone number: 0131 718 1093 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
19th May 202610:20 amRNSHolding(s) in Company
14th May 202612:26 pmRNSHolding(s) in Company
12th May 20267:00 amRNSAdaptix receives CE Certification
6th May 20264:28 pmRNSHolding(s) in Company
30th Apr 20262:42 pmRNSHolding(s) in Company
30th Apr 20262:41 pmRNSExercise of Options & TVR
24th Apr 20262:54 pmRNSHolding(s) in Company
16th Apr 20267:00 amRNSStrong Nuclear Orders for Avingtrans
26th Mar 20267:00 amRNS-RScientific Magnetics Ships 20th Quantum Magnet
4th Mar 20267:00 amRNSHolding(s) in Company
25th Feb 20267:00 amRNSInterim Results
12th Feb 202611:49 amRNSHolding(s) in Company
6th Feb 202610:24 amRNSHolding(s) in Company
27th Jan 20265:42 pmRNSExercise of Options & TVR
21st Jan 20267:00 amRNSTrading Update and Notice of Results
12th Jan 20265:13 pmRNSIssue of Share Options
12th Jan 20267:00 amRNS-RMedical & Industrial Imaging Division Appointment
8th Dec 20252:34 pmRNSNotification of Major Holdings
27th Nov 20251:59 pmRNSResult of AGM - Board Appointment
14th Nov 20258:38 amRNSExercise of Options & PDMR Dealings
10th Nov 20257:00 amRNSAdaptix receives FDA 510(K) clearance
1st Oct 20254:52 pmRNSExercise of Options & Total Voting Rights
1st Oct 20253:32 pmRNSHolding(s) in Company
29th Sep 20257:00 amRNSAppointment of Medical Division CEO
24th Sep 20257:00 amRNSPreliminary results for the year ended 31 May 2025
11th Sep 20258:00 amRNSHolding(s) in Company
2nd Sep 20257:00 amRNSHayward Tyler Secures $16m Nuclear Contracts
28th Aug 20257:00 amRNSBooth Industries secures £8.5m HS2 & TfL contracts
25th Jun 20257:00 amRNSTrading Update and Notice of Results
28th May 20257:00 amRNSTrading Update
26th Feb 20257:00 amRNSInterim Results
13th Feb 20257:00 amRNSBooth Industries secures £4.5m Contract
16th Jan 20257:00 amRNSTrading Update & Notice of Results
21st Nov 20244:09 pmRNSResult of AGM
24th Oct 20249:07 amRNSHolding(s) in Company
25th Sep 20247:00 amRNSPreliminary results for the year ended 31 May 2024
3rd Jul 20247:00 amRNSPDMR Dealings
19th Jun 20247:00 amRNSTrading Update and Notice of Results
26th Mar 202411:15 amRNSPDMR Dealings
21st Mar 20245:15 pmRNSExercise of Options, PDMR Dealings & TVR
20th Mar 20243:39 pmRNSHolding(s) in Company
4th Mar 20246:10 pmRNSPDMR Dealings
28th Feb 20247:00 amRNSInterim Results
18th Jan 20247:00 amRNSTrading Update and Notice of Results
15th Dec 20233:00 pmRNSExercise of Options & TVR
4th Dec 20237:00 amRNSMagnetica Limited appoints US distributor
22nd Nov 20237:00 amRNSEmployee & PDMR Share Incentive Awards
16th Nov 20232:20 pmRNSResult of AGM
13th Nov 20237:00 amRNSHayward Tyler Contract Win
11th Oct 20237:00 amRNSContract Wins

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.